Fingerprint
Dive into the research topics of 'Prospective, open-label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Prospective, open-label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study
Tsai Sheng Yang, Hong Hwa Chen, Lin Bo-Wen, Tae Won Kim, Jong Gwang Kim, Joong Bae Ahn, Myung Ah Lee, Johnson Lin, Gwo Fuang Ho, Le Tuan Anh, Sally Temraz, Matthew Burge, Clarinda Chua, Jason Huang, Young Suk Park
- Chang Gung Memorial Hospital
- National Cheng Kung University
- University of Ulsan
- Kyungpook National University
- Yonsei University
- Mackay Memorial Hospital Taiwan
- University of Malaya
- Cho Ray Hospital
- American University of Beirut
- Royal Brisbane and Women's Hospital
- National Cancer Centre
- Merck KGaA
- Samsung Medical Center, Sungkyunkwan university
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations